傷口護理市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球傷口護理市場價值為 249 億美元，預計到 2034 年將以 5.9% 的複合年成長率成長，達到 442 億美元。傷口護理在醫療保健中發揮著至關重要的作用，它涵蓋了各種醫療產品和解決方案，可支持傷口癒合、預防併發症並降低感染風險。隨著全球慢性病負擔的增加、老年人口的增加以及外科手術數量的增加，對先進且有效的傷口護理解決方案的需求不斷加速。由於人們對傷口管理的認知不斷提高、醫療保健支出不斷增加以及現代治療方法的迅速採用，市場正在經歷顯著的成長。

隨著醫療保健專業人員尋求更快的康復、減少住院時間和改善患者的治療效果，醫院、門診護理中心和家庭醫療保健機構對專用傷口護理產品的使用正在激增。此外，道路交通事故、燒傷和運動相關創傷的激增也推動了全球對高效傷口癒合產品的需求。監管支援、報銷政策以及智慧敷料和生物工程皮膚替代品等技術進步預計將進​​一步擴大市場的潛力。

傷口敷料產品仍然是傷口護理領域的核心，產品選擇很大程度上取決於傷口類型和嚴重程度。市場分為先進的外科傷口護理、傷口敷料、傷口治療設備、傳統傷口護理和傷口護理生物製劑。其中，先進傷口敷料領域預計將實現強勁成長，預計到 2034 年將創造 145 億美元的市場價值。這些敷料旨在最佳化水分平衡、促進組織再生、減少結痂形成，從而加速癒合。許多此類產品都含有銀、碘或蜂蜜等抗菌成分，可有效降低感染風險並促進傷口環境清潔。此外，非黏性敷料和矽基敷料可減少更換敷料時的不適感，並保護脆弱的新組織免受創傷。

傷口護理市場根據傷口類型進一步分為慢性和急性。急性傷口護理領域包括手術傷口、創傷和燒傷，2024 年的收入為 139 億美元。泡沫敷料、水凝膠和薄膜敷料等產品被廣泛用於處理這些傷口並預防感染。矽膠和水凝膠敷料等先進解決方案因其能夠最大限度地減少更換敷料時的疼痛和刺激而越來越受到關注，從而進一步推動了該領域的需求。

受慢性傷口日益普遍和人口老化的推動，美國傷口護理市場預計到 2034 年將達到 119 億美元。憑藉著高度發展的醫療保健基礎設施、不斷增加的糖尿病病例以及不斷提高的患者意識，美國仍然是全球傷口護理領域的主要貢獻者。

影響全球傷口護理市場的關鍵參與者包括 3M 公司、百特國際、Medline Industries、B. Braun Melsungen、Molnlycke Health Care、史密斯和侄子、康維德集團、美敦力、康樂保、強生、Derma Sciences 和 Integra LifeSciences。這些公司專注於持續創新，推出採用生物活性材料和抗菌技術的先進傷口護理產品。許多公司也正在擴大其產品組合併加強分銷網路，以進入新興市場並提高全球可及性。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 外科手術數量不斷增加
    • 傷口護理產品需求不斷增加
    • 糖尿病盛行率上升
    • 傷口護理產品技術不斷進步
    • 創傷病例數上升
  • 產業陷阱與挑戰
    • 替代療法的可用性
    • 新興經濟體缺乏對先進傷口護理產品的認知，導致傷口管理不當
    • 發展中國家慢性傷口的長期診斷
• 成長潛力分析
• 監管格局
• 技術格局
• 專利分析
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 年至 2034 年

• 主要趨勢
• 進階傷口敷料
  • 泡棉敷料
  • 水膠體敷料
  • 薄膜敷料
  • 藻酸鹽敷料
  • 水凝膠敷料
  • 膠原蛋白敷料
  • 其他高級敷料
• 手術傷口護理
  • 縫合線和釘書釘
  • 組織黏合劑和密封劑
  • 抗感染敷料
• 傳統傷口護理
  • 醫用膠帶
  • 棉布
  • 繃帶
  • 紗布
  • 海綿
  • 清潔劑
• 傷口治療設備
  • 負壓傷口治療
  • 氧氣和高壓氧設備
  • 電刺激裝置
  • 壓力釋放裝置
  • 其他傷口治療設備
• 傷口護理生物製劑
  • 皮膚替代品
    • 生物
      • 同種異體移植
      • 異種移植
      • 其他生物製品
    • 合成的
  • 外用藥物

第6章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 慢性傷口
  • 糖尿病足潰瘍
  • 壓瘡
  • 靜脈性腿部潰瘍
  • 其他慢性傷口
• 急性傷口
  • 手術傷口
  • 外傷
  • 燒傷

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 專科診所
• 居家照護環境
• 其他最終用途

第8章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 捷克共和國
  • 荷蘭
  • 丹麥
  • 匈牙利
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• 3M Company
• Advancis Medical
• B. Braun Melsungen
• Baxter International
• Coloplast
• ConvaTec Group
• Ethicon (Johnson and Johnson)
• Derma Sciences (Integra LifeSciences)
• Medline Industries
• Medtronic
• Molnlycke Health Care
• Smith and Nephew
• URGO Medical

The Global Wound Care Market was valued at USD 24.9 billion in 2024 and is estimated to grow at a CAGR of 5.9% to reach USD 44.2 billion by 2034. Wound care plays a critical role in healthcare by encompassing a wide range of medical products and solutions that support the healing of wounds, prevent complications, and reduce the risk of infections. With the rising global burden of chronic diseases, an increasing geriatric population, and a growing number of surgical procedures, the demand for advanced and effective wound care solutions continues to accelerate. The market is experiencing a significant boost due to heightened awareness around wound management, increasing healthcare expenditure, and the rapid adoption of modern treatment approaches.

Hospitals, outpatient care centers, and home healthcare settings are witnessing a surge in the use of specialized wound care products as healthcare professionals seek faster healing, reduced hospital stays, and improved patient outcomes. In addition, the surge in road accidents, burn injuries, and sports-related trauma is also pushing demand for efficient wound healing products globally. Regulatory support, reimbursement policies, and technological advancements such as smart dressings and bioengineered skin substitutes are expected to further expand the market's potential.

Wound dressing products remain at the core of the wound care segment, with product selection depending heavily on the wound type and severity. The market is segmented into advanced surgical wound care, wound dressing, wound therapy devices, traditional wound care, and wound care biologics. Among these, the advanced wound dressing segment is poised for robust growth, projected to generate USD 14.5 billion by 2034. These dressings are designed to optimize moisture balance, promote tissue regeneration, and minimize scab formation, all of which accelerate healing. Many of these products feature antimicrobial components such as silver, iodine, or honey, effectively lowering infection risk and promoting a clean wound environment. Additionally, non-adherent and silicone-based dressings reduce discomfort during dressing changes and protect delicate new tissues from trauma.

The wound care market is further categorized based on wound type-chronic and acute. The acute wound care segment, which includes surgical wounds, trauma injuries, and burns, accounted for USD 13.9 billion in revenue in 2024. Products such as foam dressings, hydrogels, and film dressings are widely used to manage these wounds and prevent infection. Advanced solutions like silicone and hydrogel dressings are gaining traction for their ability to minimize pain and irritation during dressing changes, driving further demand in this segment.

The U.S. Wound Care Market is anticipated to reach USD 11.9 billion by 2034, driven by the growing prevalence of chronic wounds and an aging population. With a highly developed healthcare infrastructure, increasing diabetes cases, and rising patient awareness, the U.S. remains a major contributor to the global wound care landscape.

Key players shaping the global wound care market include 3M Company, Baxter International, Medline Industries, B. Braun Melsungen, Molnlycke Health Care, Smith and Nephew, ConvaTec Group, Medtronic, Coloplast, Johnson & Johnson, Derma Sciences, and Integra LifeSciences. These companies focus on continuous innovation, launching advanced wound care products with bioactive materials and antimicrobial technologies. Many are also expanding their portfolios and strengthening distribution networks to tap into emerging markets and improve global accessibility.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of surgical procedures
    • 3.2.1.2 Rising demand for wound care products
    • 3.2.1.3 Rising prevalence of diabetes
    • 3.2.1.4 Growing technological advancements in wound care products
    • 3.2.1.5 Rise in number of trauma cases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of alternative therapies
    • 3.2.2.2 Improper wound management due to lack of awareness of advanced wound care products in emerging economies
    • 3.2.2.3 Prolonged diagnosis of chronic wounds in developing countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Patent analysis
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Products, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Advanced wound dressing
  • 5.2.1 Foam dressings
  • 5.2.2 Hydrocolloid dressings
  • 5.2.3 Film dressings
  • 5.2.4 Alginate dressings
  • 5.2.5 Hydrogel dressings
  • 5.2.6 Collagen dressings
  • 5.2.7 Other advanced dressings
• 5.3 Surgical wound care
  • 5.3.1 Sutures and staples
  • 5.3.2 Tissue adhesive and sealants
  • 5.3.3 Anti-infective dressing
• 5.4 Traditional wound care
  • 5.4.1 Medical tapes
  • 5.4.2 Cotton
  • 5.4.3 Bandages
  • 5.4.4 Gauzes
  • 5.4.5 Sponges
  • 5.4.6 Cleansing agents
• 5.5 Wound therapy devices
  • 5.5.1 Negative pressure wound therapy
  • 5.5.2 Oxygen and hyperbaric oxygen equipment
  • 5.5.3 Electric stimulation devices
  • 5.5.4 Pressure relief devices
  • 5.5.5 Other wound therapy devices
• 5.6 Wound care biologics
  • 5.6.1 Skin substitutes
    • 5.6.1.1 Biological
      • 5.6.1.1.1 Allograft
      • 5.6.1.1.2 Xenograft
      • 5.6.1.1.3 Other biologicals
    • 5.6.1.2 Synthetic
  • 5.6.2 Topical agents

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic wounds
  • 6.2.1 Diabetic foot ulcers
  • 6.2.2 Pressure ulcers
  • 6.2.3 Venous leg ulcers
  • 6.2.4 Other chronic wounds
• 6.3 Acute wounds
  • 6.3.1 Surgical wounds
  • 6.3.2 Traumatic wounds
  • 6.3.3 Burns

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Home care settings
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
  • 8.3.7 Czech Republic
  • 8.3.8 Netherlands
  • 8.3.9 Denmark
  • 8.3.10 Hungary
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 3M Company
• 9.2 Advancis Medical
• 9.3 B. Braun Melsungen
• 9.4 Baxter International
• 9.5 Coloplast
• 9.6 ConvaTec Group
• 9.7 Ethicon (Johnson and Johnson)
• 9.8 Derma Sciences (Integra LifeSciences)
• 9.9 Medline Industries
• 9.10 Medtronic
• 9.11 Molnlycke Health Care
• 9.12 Smith and Nephew
• 9.13 URGO Medical